DetailsChartProfilRisikomatrixNachrichtenDokumente

BIT Biotech Opportunities S/  DE000A3DCA95  /

Fonds
NAV25.07.2024 Diff.-2,0700 Ertragstyp Ausrichtung Fondsgesellschaft
140,1200EUR -1,46% thesaurierend Aktien HANSAINVEST ▶
     
Chart for BIT Biotech Opportunities S
  Titel   ISIN Performance Volatilität Sharpe Ratio
1. Janus Henderson Horizon Biotechnology Fund IU2 EUR LU2441282626 +39,30% 20,14% 1,77
2. Janus Henderson Horizon Biotechnology Fund A2 EUR LU2441282899 +39,00% 20,45% 1,73
3. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD LU0320765992 +34,37% 18,10% 1,70
4. J.Henderson H.BioTech.F.IU2 LU1897414568 +37,02% 22,05% 1,51
5. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP LU0774687577 +34,18% 18,00% 1,70
6. J.Henderson H.BioTech.F.H2 LU1897414485 +36,81% 22,04% 1,50
7. DWS ESG Biotech FC DE000DWS2WY7 +33,18% 18,68% 1,58
8. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD LU0195948822 +33,70% 19,17% 1,57
9. F.Biotechnology Dis.Fd.W USD LU0976566496 +33,57% 19,20% 1,56
10. DWS ESG Biotech TFC DE000DWS2UA1 +32,99% 18,68% 1,57
...
71. BIT Biotech Opportunities S DE000A3DCA95 +18,74% 32,89% 0,46